Baltimore, WV
Chelation Therapy clinics in Baltimore
Chelation therapy in Baltimore is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most Baltimore chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in Baltimore, Maryland, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
No clinics found
Reset all filtersRegulatory context
A note on West Virginia's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
West Virginia Medical Practice Act (W. Va. Code Chapter 30 Article 3)
Only physicians licensed by the West Virginia Board of Medicine or Board of Osteopathic Medicine may diagnose and treat, including prescribing chelating agents. -
West Virginia Pharmacy Practice Act (W. Va. Code Chapter 30 Article 5)
Governs compounded DMPS and other chelating preparations.
The West Virginia Board of Medicine investigates complaints involving chelation marketed for autism, atherosclerosis, or Alzheimer's disease without adequate informed consent or evidence base. The 2005 Pittsburgh pediatric autism chelation death prompted national board guidance reinforcing that the wrong EDTA salt (Na2EDTA versus CaNa2EDTA) can be fatal, and West Virginia incorporates these safety standards. Compounded DMPS distribution is subject to pharmacy law enforcement.
Chelation Therapy in Baltimore, answered.
Explore related care